|
TEAD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.60946861078082E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12679865438281E-11 |
| Normal-vs-Stage2 |
1.866000E-01 |
| Normal-vs-Stage3 |
1.96283999999158E-05 |
| Normal-vs-Stage4 |
4.421900E-02 |
| Stage1-vs-Stage2 |
2.755400E-04 |
| Stage1-vs-Stage3 |
7.965800E-01 |
| Stage1-vs-Stage4 |
1.659580E-01 |
| Stage2-vs-Stage3 |
6.742400E-03 |
| Stage2-vs-Stage4 |
2.852800E-01 |
| Stage3-vs-Stage4 |
2.846600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.36609612511052E-11 |
| Normal-vs-AfricanAmerican |
7.758000E-02 |
| Normal-vs-Asian |
3.42639999995065E-06 |
| Caucasian-vs-AfricanAmerican |
9.255000E-01 |
| Caucasian-vs-Asian |
3.134600E-01 |
| AfricanAmerican-vs-Asian |
7.175400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.13500000012523E-07 |
| Normal-vs-Female |
8.61580029543063E-10 |
| Male-vs-Female |
1.561640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.78169956355623E-10 |
| Normal-vs-Age(41-60Yrs) |
4.22129999955168E-07 |
| Normal-vs-Age(61-80Yrs) |
2.451700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.197360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.644600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.022400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.658800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.043380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.243600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.079600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.980000E-01 |
| Classical-VS-Follicular |
5.77600000051248E-07 |
| Classical-VS-Other |
4.536600E-01 |
| Classical-VS-Normal |
1.62736490949555E-12 |
| Tall-VS-Follicular |
3.692200E-02 |
| Tall-VS-Other |
3.769200E-01 |
| Tall-VS-Normal |
8.658800E-03 |
| Follicular-VS-Other |
2.360400E-01 |
| Follicular-VS-Normal |
4.169200E-01 |
| Other-VS-Normal |
2.115200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.76830000003991E-06 |
| Normal-vs-N1 |
6.963000E-03 |
| N0-vs-N1 |
9.403400E-01 |
|
|
